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Infective endocarditis (IE) is a life-threatening infection of the heart endothelium and valves. Staphylococcus aureus is a pre-
dominant cause of severe IE and is frequently associated with infections in health care settings and device-related infections.
Multilocus sequence typing (MLST), spa typing, and virulence gene microarrays are frequently used to classify S. aureus clinical
isolates. This study examined the utility of these typing tools to investigate S. aureus epidemiology associated with IE. Ninety-
seven S. aureus isolates were collected from patients diagnosed with (i) IE, (ii) bloodstream infection related to medical devices,
(iii) bloodstream infection not related to medical devices, and (iv) skin or soft-tissue infections. TheMLST clonal complex (CC)
for each isolate was determined and compared to the CCs of members of the S. aureus population by eBURST analysis. The spa
type of all isolates was also determined. A null model was used to determine correlations of IE with CC and spa type. DNAmi-
croarray analysis was performed, and a permutational analysis of multivariate variance (PERMANOVA) and principal coordi-
nates analysis were conducted to identify genotypic differences between IE and non-IE strains. CC12, CC20, and spa type t160
were significantly associated with IE S. aureus. A subset of virulence-associated genes and alleles, including genes encoding
staphylococcal superantigen-like proteins, fibrinogen-binding protein, and a leukocidin subunit, also significantly correlated
with IE isolates. MLST, spa typing, and microarray analysis are promising tools for monitoring S. aureus epidemiology associ-
ated with IE. Further research to determine a role for the S. aureus IE-associated virulence genes identified in this study is
warranted.
Infective endocarditis (IE) is a life-threatening infection of theendocardial surfaces of the heart and heart valves (1, 2). Antibi-
otic therapy is often difficult due to causation by multidrug-resis-
tant bacteria and the capacity of infecting bacteria to form bio-
films on the heart endothelium or implanted medical devices (3).
Staphylococcus aureus is the predominant cause of the most severe
cases of IE and is the most common pathogen isolated from cases
related to intravenous drug use, health care environments, and
medical devices such as prosthetic heart valves and intravenous
catheters (4–8). The potential of S. aureus to colonize the heart
endothelium and cause IE is thought to be closely associated with
the genotype of infecting strains (9–11).
Genotyping methods, such as multilocus sequence typing
(MLST) and spa typing, have been developed to classify andmon-
itor the S. aureus population. MLST involves assigning strains a
sequence type (ST) based on allelic variations in seven genes in the
core genome (arc, aroE, glpF, gmk, pta, tpi, and yqi). Strains that
diverge at nomore than one of the sevenMLST loci are considered
to belong to the same clonal complex (CC). Double-locus variants
(dlvs) are included in the CC if the linking single-locus variant
(slv) is present in the MLST database (http://eburst.mlst.net). S.
aureus isolated frompatients with IE have generally been classified
into CC1, CC5, CC8, CC15, CC30, and CC45 (10–12), with the
majority belonging to CC30 (10). It has indeed been suggested
that CC30 is more closely associated with IE than with other types
of S. aureus infections (10). However, other studies have found no
association between CC and invasive disease (12–14).
spa typing involves amplification and sequencing of the hyper-
variable region of the spa gene, which encodes the surface-exposed
staphylococcal protein A, a major S. aureus virulence factor (15).
A spa type is assigned to a S. aureus strain according to the number
and combination of variable short repeats (24 bp) which are lo-
cated in the C terminus of the spa gene and are flanked by well-
conserved regions. Associations between spa type and IE have not
been reported.
Bacterial pathogenicity and the development of IE are under-
pinned by the presence of virulence genes that encode factors such
as adhesins, toxins, and exoproteins. Fibronectin-binding protein
A and B (FnBPA/FnBPB) and Clumping Factor A (ClfA) are well-
characterized Microbial Surface Components Recognizing Adhe-
sive Matrix Molecules (MSCRAMMs) that mediate attachment
and colonization of S. aureus to the heart endothelium and med-
ical devices (16–19). The capsular polysaccharide is another im-
portant virulence factor expressed by most clinical strains of S.
aureus. The capsule prevents phagocytosis of the bacterium by
host immune cells, thus facilitating the persistence of S. aureus
within the host and development of disease (20, 21).
A recent analysis of individual S. aureus virulence genes and S.
aureus IE strains found no correlation between S. aureus genotype
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and IE (12). However, complex bacterial phenotypes such as the
capacity to cause IE are likely to be underpinned by multiple ge-
netic determinants. This study therefore examined associations of
CC, spa type, and carriage of multiple virulence-associated genes
with S. aureus IE. We identify CCs and spa types that are signifi-
cantly associated with IE isolates and define a set of virulence-
associated genes and allelic variants that, when combined, are sig-
nificantly correlatedwith S. aureus IE isolates compared to non-IE
isolates.
MATERIALS AND METHODS
Bacterial isolates. Ninety-seven S. aureus clinical isolates were collected
between 2003 and 2007 from patients admitted to metropolitan hospitals
in Brisbane, Australia. These hospitals included the Royal Brisbane and
Women’s Hospital, Ipswich Hospital, and Princess Alexandra Hospital.
Isolates were categorized according to the clinical outcome associated
with the respective patients: (i) IE (n  24), (ii) bloodstream infection
related to a medical device (BSI-D; n  17), (iii) bloodstream infection
not related to a medical device (BSI-ND; n  32), and (iv) skin or soft-
tissue infection (SSTI; n 24). S. aureus endocarditis was defined accord-
ing to the modified Duke Criteria (22).
Preparation of genomicDNA. Bacteria were grown overnight on Co-
lumbia blood agar. To prepare genomic DNA, six to eight colonies were
suspended in 100 l of lysis solution, which contained 0.05 mg lyso-
staphin (Sigma, Steinheim, Germany), 2 mg lysozyme (Sigma), 2 mg
RNase A (Sigma), 2 l 20 mM Tris-HCl (pH 8.0), 2 l 2 mM EDTA, and
1l Triton X-100. The suspension was incubated at 37°C for 45 min with
aeration (300 rpm). Proteinase K (10l) and buffer AL (100l) (DNeasy
kit; QIAgen, Hilden, Germany) were added, and the suspension was in-
cubated at 56°C for 45min. The DNAwas then processed using a QIAgen
EZ1 device according to the manufacturer’s tissue lysis protocol.
Multilocus sequence typing and eBURST analysis. MLST was per-
formed as previously described (23). Briefly, primers were designed to
PCR amplify seven defined S. aureus genes (arc, aroE, glpF, gmk, pta, tpi,
and yqi). The PCR products were purified using a PCR purification kit
(QIAgen), and both strands were sequenced using a CEQ 8000 genetic
analysis system (Beckman Coulter, High Wycombe, United Kingdom).
The sequences were aligned and analyzed using BioNumerics software
(Applied Maths, St-Martens-Latem, Belgium). Allelic profiles and STs
were assigned, and an MLST tree was constructed using the MLST data-
base (http://www.mlst.net). STs were analyzed and assigned into CCs by
the use of eBURST software (http://eburst.mlst.net). Strains that diverged
at no more than one of the sevenMLST loci were considered to belong to
the sameCC.Double-locus variants were included in the CC if the linking
single-locus variant was present in theMLST database. The STs for strains
SA4, SA6, SA7, and SA18 were assigned based on99% sequence conser-
vation for yqi, tpi, aroE, and tpi alleles, respectively. The isolates were
compared with each other as well as with the entire S. aureus population
available in the MLST database at the time of the study.
spa typing. The hypervariable region of the spa gene was amplified
using Taq DNA polymerase (QIAgen) according to the manufacturer’s
protocol and using primers designed as previously described (24): 1095F
(5=-AGACGATCCTTCGGTGAGC) and 1517R (5=-GCTTTTGCAATGT
CATTTACTG). PCR cycling conditionswere as follows: an initial 3min at
94°C; 30 cycles of 30 s at 94°C, 30 s at 55°C, and 1 min at 72°C; and a final
10min at 72°C. The PCR product was purified using aWizard SVGel and
PCR Clean Up system (Promega, Madison,WI). The forward and reverse
strands of the purified PCR product were sequenced using BigDye Termi-
nator v3.1 according to themanufacturer’s protocol (Applied Biosystems,
Foster City, CA). The sequences were analyzed and spa types assigned
using the spaType Finder (http://fortinbras.us/cgi-bin/spaTyper/spa
Typer.pl) and the Ridom SpaServer database (http://spa.ridom.de).
DNA microarray analysis. The DNA microarray and reagents were
obtained from Alere Technologies (Jena, Germany). The principle of the
assay and related procedures have been described previously (25, 26).
Briefly, the assay employs a linear PCR-like approach to amplify and label
target DNA. In this approach, the array is stained by horseradish peroxi-
dase-based tetramethylbenzidine precipitation for 10 to 30 min, after
which the resulting pattern is recorded and analyzed using an ATR01
reader (CLONDIAG) and IconoClust software (CLONDIAG). The raw
data were interpreted as previously described (25, 26).
The DNA array targets, primers, and probes used in the study have
been previously published (27). The array covered 352 target sequences
consisting of a variety of species markers, markers for accessory gene
regulator (agr) alleles and capsule types, virulence factors, resistance
genes, staphylococcal superantigen-like and exotoxin-like genes (set and
ssl), and genes encoding adhesins. Depending upon the nomenclature
used, the target sequences correspond to 185 distinct genes and their
allelic variants. All probes were specific to their target gene, were not
self-hybridizing, and were similar with respect to GC content, length, and
melting temperature. The probes were analyzed against the GenBank
database (http://www.ncbi.nlm.nih.gov/BLAST/) to eliminate probes
that might cause false-positive or false-negative reactions.
Statistical analysis of CC, spa type, and microarray data. To deter-
mine the correlation between the presence of each CC, spa type, and IE
isolates, a null model with 1,000 permutations was used. In each permu-
tation, eachCC/spa typewas randomly assigned to a strain. The difference
between the percentage of IE strains with that CC/spa type and the per-
centage likely to be obtained by chance was calculated. The percentages
obtained in the 1,000 permutations were then used to calculate the likeli-
hood of the observed difference occurring by chance. A correlationmatrix
was built to explore the correlation between the presence of each CC and
each spa type.
Permutational analysis of multivariate variance (PERMANOVA) was
used to determine if there were genotypic differences between IE and
non-IE strains. A principal coordinates (PCO) analysis was used to rep-
resent the genotype in a two-dimensional graphical space. To identify
groups of genes that were present in IE isolates, the correlation coefficient
values corresponding to the presence or absence of each gene and the first
two axes of the PCO were calculated. Groups of genes or alleles with
correlations that corresponded to regions associatedwith IE isolates in the
multivariate space were then identified.
RESULTS
Patients and isolates.Ninety-seven S. aureus clinical isolates were
collected from patients representing four disease categories: IE,
BSI-D, BSI-ND, and SSTI. A summary of the characteristics of
patients for each type of infection is presented in Table 1. There
was no significant difference in themedian ages of patients and the
clinical outcomes. More males were diagnosed with IE than fe-
males (7:1). Only five of the 97 S. aureus isolates were methicillin-
resistant S. aureus (MRSA) isolates. All five MRSA isolates were
from bloodstream infections not associated with IE.
Analysis of CCs associated with IE S. aureus isolates. Previ-
TABLE 1 Characteristics of 97 patients diagnosed with S. aureus IE,
BSI-D, BSI-ND, and SSTIa
Characteristic
Values
IE
(n 24)
BSI-D
(n 17)
BSI-ND
(n 32)
SSTI
(n 24)
Median age in yr (range) 55 (28–83) 58 (0–88) 67 (0–92) 34 (4–86)
No. (%) of female patients 3 (13) 9 (53) 10 (31) 15 (63)
No. (%) of patients with
MRSA infection
0 (0) 2 (12) 3 (9) 0 (0)
a BSI-D, bloodstream infection related to a medical device; BSI-ND, bloodstream
infection not related to a medical device; SSTI, skin or soft-tissue infection; MRSA,
methicillin-resistant S. aureus.
Nethercott et al.
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ous studies have suggested an association between S. aureus CC
and the type and severity of infection (9–11). The ST of all 97 S.
aureus isolates was therefore determined, and 27 different STs
were identified. Sixteen different STswere identified among the 24
IE isolates (Table 2).
An eBURST analysis was conducted to group STs into CCs and
to determine if particular CCswere associatedwith IE. Strains that
diverged at no more than one of the seven MLST loci were con-
sidered to belong to the same CC. The clustering of STs into CCs
allowed visualization of how the isolates were distributed among
the members of the global S. aureus population (Fig. 1). The IE
isolates were distributed across several CCs, and isolates with dif-
ferent clinical outcomes were assigned the same CC. We found
that CC12 and CC20 were significantly positively associated with
IE isolates and that CC45was negatively associatedwith IE isolates
in this study (Table 3).
Analysis of spa types associated with IE S. aureus isolates.
Two IE isolates contained novel spa sequences and were therefore
designated new spa types from the Ridom SpaServer: t11474 for
isolate 22 and t11475 for isolate 24. The prevalence of IE and
non-IE isolates within each spa type was analyzed, and a signifi-
cant association was found between spa type t160 and IE isolates
(P 0.05). A significant correlationwas also found betweenCC12
and spa type t160 (P  0.05). However, most CCs in this study
were associated with a number of spa types (Fig. 2).
Analysis of virulence genes associated with IE S. aureus iso-
lates. A number of genes, including the protease sspA, sspB, and
TABLE 2 Characteristics of MSSA clinical isolates associated with IEa
Isolate
Sex of
patient
Age of
patient (yr) ST Capsule
1 M 66 12 8
2 M 59 15 8
3 M 35 72 5
4 M 83 12 8
5 M 74 1 8
6 M 35 8 5
7 F 73 78 8
8 M 77 20 5
9 M 62 641 5
10 M 27 5 5
11 M 31 20 5
12 F 33 20 5
13 M 21 97 5
14 M 69 1273 8
15 M 70 30 8
16 M 49 78 8
17 M 76 101 8
18 M 56 188 8
19 M 53 795 8
20 M 39 30 8
21 M 45 5 5
22 M 28 8 5
23 M 30 291 5
24 F 65 8 5
a F, female; M, male; ST, sequence type; Capsule, capsular serotype.
FIG 1 eBURST analysis showing phylogenetic relatedness of the 97 clinical S. aureus isolates with the S. aureus population. The number of individual isolates is
written in a box next to the respective ST. The isolates are color coded according to clinical outcome: red for IE, blue for BSI-D, green for BSI-ND, and gray for
SSTI. The ST number is provided beside the respective box or within the founder group. The CC number is shown in black, whereas a ST belonging to the CC
is shown in purple. CCs were defined as all isolates within the group having at least six of the seven alleles identical with those of at least one other isolate in the
group (http://eburst.mlst.net). CC12 and CC20 are significantly positively associated with IE, and CC45 is significantly negatively associated with IE (P 0.05).
Characterization of Endocarditis S. aureus
July 2013 Volume 51 Number 7 jcm.asm.org 2133
 o
n
 O
ctober 12, 2014 by QUEENSLAND UNIV OF TECH
http://jcm.asm.org/
D
ow
nloaded from
 
sspP genes, the biofilm-associated icaA, icaC, and icaD genes, the
microbial surface components recognizing adhesive matrix mol-
ecules (MSCRAMMs) staphylococcal protein A (spa), clumping
factor A (clfA), clumping factor B (clfB), enolase (eno), and fi-
bronectin-binding protein A (fnbA) genes, and immune evasion
transferrin-binding protein A (isdA) and type I site-specific
DNase subunit (hsdSx) genes, were identified in all 97 isolates. The
genes that showed variation between the isolates were analyzed to
determine if any gene or gene set was more closely associated with
the IE isolates than with the non-IE isolates. PERMANOVA re-
sults suggest that there is a marked difference between IE and
non-IE strains (Sheudo-F 3.0241;P 0.01) The PCO shows the
ordination of the different genes and alleles in a compressed two-
dimensional space (Fig. 3). Isolates that clustered shared similar
genotypes, whereas isolates that were spatially separated had
greater genotypic variation.
The majority of the IE isolates (n 21; 88%) clustered on the
right of the plot and contained the ssl03, ssl7-set1, ssl8-set12, ssl08,
ssl9-set5, and setB3 genes, the fibrinogen binding protein (fib)
gene, and the leukocidin/hemolysin toxin family protein lukY-
var1 gene (Fig. 3). In contrast, a largely non-IE isolate cluster on
the left of the plot (which included IE isolate 15) did not contain
these genes or contained allelic variants of these genes. A different
set of genes and alleles, including ssl9-set5 (MRSA252), setB3
(MRSA252), lukY-var2, type I site-specific DNase subunit, 2nd
locus (hsdS2) (MRSA252), ssl4-set9 (MRSA252, SAR0425), ssl5-
set3 (MRSA252), and setB2, was present in this largely non-IE
isolate cluster. The gene set ssl03, ssl7-set1, ssl8-set12, ssl08, ssl9-
set5, setB3, fib, and lukY-var1 was significantly associated with IE
isolates compared with the non-IE isolates (P 0.05).
Variation was also observed in the genes that encode serotype-
specific capsular polysaccharides. The S. aureus isolates in this
study contained either cap5 genes (n  32; 33%) or cap8 genes
(n 65; 67%). Among the 24 IE isolates, the cap5 and cap8 genes
were equally distributed. Four of the cap5 IE isolates clustered into
a tight subgroup (Fig. 3; dotted oval), themajority of whosemem-
bers were IE isolates (n  4; 80%). The other isolate within this
subgroup was from a patient with a bloodstream infection related
to a hemodialysis intravascular device. The differentiation of this
subgroup from the other IE cap5 isolates is attributable to subspe-
cies allelic variations between several genes, including those en-
coding glutamyl endopeptidase (sspA) and bone sialoprotein-
binding protein (bbp), clfA, clfB, fnbA, fnbB, and the gene
encoding von Willebrand factor-binding protein (vwb).
DISCUSSION
In this study, we determined the CC, spa type, and virulence-
associated gene content of 24 S. aureus isolates associated with IE
and compared these profiles to those of a set of S. aureus strains
isolated from patients with different clinical syndromes from the
same geographic location. Two CCs, one spa type, and a discrete
set of virulence-associated genes and allelic variants displayed sig-
nificant correlations with IE.
Although some studies have found no significant associations
between CC and invasive disease (12, 13), it has also been sug-
gested that IE S. aureus isolates generally belong to CC1, CC5,
CC8, CC15, CC30, andCC45 (9, 10, 12). In this study, a total of 19
CCs were identified from the 97 clinical S. aureus isolates; these
included 13 CCs containing IE isolates. Only 11 of the 24 IE iso-
lates belonged to CC1, CC5, CC8, CC15, CC30, or CC45. Two IE
isolates (8%) comparedwith nine non-IE isolates (12%) belonged
to CC30; thus, there was no significant association between CC30
and IE in our study set. In contrast, we found that CC12 andCC20
were significantly positively associated with IE isolates and that
CC45 was negatively associated with IE. The difference between
this study and previous studies is most likely due to the different
strain sets analyzed; for example, genetic variation exists between
strains from different geographic locations (10).
As no previous study has reported a correlation between spa
type and IE, spa typing was performed in this work to determine if
particular spa types were associated with IE. spa type t160 was
significantly associated with IE. A significant correlation was also
found between CC12 and spa type t160. Most CCs in this study
were associated with a number of spa types.
ADNAmicroarray and PERMANOVAwere also performed to
determine if known S. aureus virulence genes were associated with
IE isolates. Analysis of the DNAmicroarray data clustered isolates
into three main groups. Isolates between clusters differed in the
presence of the genes and allelic variants ssl03, ssl7-set1, ssl8-set12,
ssl08, ssl9-set5, setB3, fib, and lukY-var1 and the presence of cap5 or
cap8 genes. The set of genes and allelic variants was significantly
associated with IE isolates compared with non-IE isolates (P 
0.05). This result differs from those of a recent study by Tristan et
al. in which no difference between IE and non-IE S. aureus isolates
in the prevalences of individual virulence-associated genes was
found. A two-tailed Fisher’s exact test was used in this recent
study, which analyzed the results obtained with each gene inde-
pendently (12). However, the PERMANOVA used in the current
work was able to identify correlations between gene sets and
clinical outcome. As multiple genes are likely to contribute to
complex phenotypes such as the capacity to cause bacterial IE, the
PERMANOVA is better suited to predict a gene repertoire that
correlates with disease.
The identified S. aureus-IE gene set contains a number of genes
TABLE 3 Relationship between CC and spa type with IE strainsa
CC % difference P spa type % difference P
CC12 11.13 0.007 t160 6.96 0.003
CC20 9.76 0.012 t021 4.167 0.08
CC8 7.02 0.06 t024 4.167 0.08
CC101 4.167 0.27 t164 4.167 0.08
CC291 4.167 0.27 t267 4.167 0.08
CC72 4.167 0.27 t537 4.167 0.08
CC97 4.167 0.27 t888 4.167 0.08
CC1 0.057 0.49 t937 4.167 0.08
CC188 0.057 0.49 t1333 4.167 0.08
CC39 1.37 0.43 t1987 4.167 0.08
CC6 1.37 0.43 t11474 4.167 0.08
CC93 1.37 0.43 t11475 4.167 0.08
CC15 4 0.241 t002 2.91 0.238
CC30 4 0.241 t037 4.11 0.14
CC109 4.11 0.24 t371 4.11 0.14
CC121 4.11 0.24 t186 5.48 0.06
CC5 6.68 0.18
CC88 8.11 0.07
CC45 9.59 0.04
a % difference values represent the difference between the percentage of IE strains with
that CC/spa type and the percentage likely to be obtained by chance. P values represent
the probability that the difference between the percentages of IE and non-IE strains
associated with each type was obtained by chance. Negative correlations are indicated
with boldface characters.
Nethercott et al.
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FIG 2 A phylogenetic tree based on the ST of the 97 clinical S. aureus isolates and USA300. The spa type and isolate number are shown next to the respective ST.
Isolates are color coded according to clinical outcome: red for IE, blue for BSI-D, green for BSI-ND, and gray for SSTI. The tree was constructed using theMLST
database (http://www.mlst.net). CC12 and t160 were significantly associated with IE (P 0.05).
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that encode superantigen-like proteins (Ssls), previously known
as staphylococcal exotoxin-like proteins (Sets). All known ssl-set
genes are located onmobile genetic elements, with set6–15 located
in a 19-kb region on staphylococcal pathogenicity island 2 (28,
29). Ssl/Set proteins are structurally homologous to staphylococ-
cal superantigens but lack superantigenic properties such as mi-
togenicity, pyrogenicity, and inducement of endotoxic shock (28,
30). Although defined functions have not yet been assigned to
every Ssl/Set protein, the members of this family of proteins are
collectively known to mediate immune evasion by inhibiting
complement activation and binding to IgA and IgG and prevent-
ing the recruitment and function of neutrophils (31).
The fib gene encodes an extracellular fibrinogen binding pro-
tein (Efb), which is secreted by S. aureus during infection (32). Efb
plays a number of important roles during pathogenesis. The pro-
tein binds to host fibrinogen (Fg) and platelets and therefore
blocks the binding of Fg to neutrophils and inhibits platelet aggre-
gation (33–35). Efb also binds to C3b, which minimizes B and T
cell responses, and inhibits complement-mediated opsonization
and phagocytosis (36, 37).
The lukY gene encodes a leukocidin subunit which is not asso-
ciated with the well-characterized Panton-Valentine leukocidin
(PVL) lukF-PV and lukS-PV genes. It is important to highlight
that, according to our analysis (as partially supported by previous
results [12]), the gene sets identified as positively or negatively
related to IE appear to have a synergistic effect. It could therefore
bemisleading to infer that each independentmember of each gene
subset has a direct independent effect on IE.
The PCO analysis revealed that some isolates from different
CCs clustered, such as isolate 12 (CC97) clustering with isolates 6,
22, and 24 (CC8). This observation is not surprising, as virulence-
associated genes are readily passed horizontally between unrelated
strains via homologous recombination or acquisition of mobile
elements (38). In contrast, genes in the core genome, such as the
sevenMLST genes, are vertically acquired from a common ances-
tor and evolve more slowly. The CC or spa type alone does not
indicate the potential of an isolate to cause disease (13).
It is likely that there are other S. aureus virulence determinants
associated with IE that were not identified due to their absence from
theDNAmicroarray. In addition, all IE strains analyzed in this study
weremethicillin-susceptible S. aureus (MSSA), and it is possible that
there are differences betweenMSSA andMRSA strains in IE-associ-
ated genes. For example, MSSA and MRSA utilize different mecha-
nisms for biofilm growth (39).MRSA strains typically utilize protein
adhesins such as FnBP to form biofilms, whereas biofilm formation
by MSSA strains is generally dependent on production of the
polysaccharide adhesin polymeric N-acetylglucosamine. In addi-
tion, a combination of host factors (e.g., age, gender, and immune
status)may contribute to the capacity of S. aureus to cause IE in an
individual.
In conclusion, we have determined that CC12, CC20, and t160
are significantly associated with the IE-related S. aureus isolates
used in this study. These two CCs and this spa type could be used
to differentiate S. aureus strains which have the potential to cause
IE from less virulent S. aureus strains. We have also identified S.
aureus genes and allelic variants, namely, ssl03, ssl7-set1, ssl8-set12,
ssl08, ssl9-set5, setB3, fib, and lukY-var1, which are significantly
associated with IE. These IE-associated genes may provide a
FIG 3 Ordination of the 97 clinical S. aureus isolates based on the first two axes of a PCO corresponding to the presence or absence of 352 target sequences. The
presence of the genes and allelic variants was determined using a DNAmicroarray, and the 265 targets showing variation among the isolates were analyzed by a
PERMANOVA and distributed in a PCO. Isolates are color coded according to clinical outcome: red for IE, blue for BSI-D, green for BSI-ND, and gray for SSTI.
Genes are listed in the boxes next to the cluster containing isolates positive for the respective genes. The genes in the set consisting of ssl03, ssl7-set1, ssl8-set12,
ssl08, ssl9-set5, setB3, fib, and lukY-var1 are significantly associated with the IE isolates (P  0.05). The isolates within the dotted cluster differ from other
cap5-positive IE isolates by subspecies allelic variations in several genes (lukS, sspA, ssl1-set6, ssl01, ssl11-set2, bbp, clfA, clfB, fnbA, fnbB, sdrC, sasG, hsdS3,
Q2FXCO, and vwb).
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framework for further study to investigate the virulence of S. au-
reus strains associated with IE.
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